| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SYNSAM
|
54.90 | 7.8B | 3.38 | 3.07 | 2.10 | 10.7% | 8.2% | 82 | 70 | 115.39 | +82.6% | 62 | 1.45 |
|
RVRC
|
53.10 | 5.6B | 4.16 | 4.37 | 3.03 | 34.5% | 10.4% | 79 | 82 | 92.15 | +55.2% | 87 | 0.01 |
|
BILI_A
|
143.60 | 13.2B | 3.91 | 2.66 | 2.80 | 6.9% | 6.8% | 78 | 65 | 276.46 | +69.4% | 54 | 2.14 |
|
BMAX
|
51.50 | 3.0B | 3.24 | 1.19 | 2.45 | 5.6% | 7.7% | 77 | 66 | 127.70 | +111.0% | 61 | 0.76 |
|
CLAS_B
|
431.00 | 24.9B | 5.33 | 8.69 | 3.71 | 40.7% | 9.0% | 76 | 79 | 622.27 | +33.3% | 81 | 0.66 |
|
BOOZT
|
145.50 | 8.5B | 7.05 | 3.29 | 4.10 | 10.0% | 9.8% | 70 | 58 | 212.34 | +34.5% | 67 | 0.29 |
|
AXFO
|
237.10 | 51.2B | 5.26 | 7.60 | 3.19 | 10.1% | 7.6% | 69 | 65 | 357.11 | +36.4% | 53 | 2.36 |
|
BHG
|
19.61 | 3.5B | 9.86 | 0.60 | 2.96 | 3.4% | 7.6% | 68 | 58 | 37.61 | +68.8% | 65 | 0.41 |
|
RUSTA
|
79.45 | 12.2B | 5.53 | 5.61 | 3.90 | 9.3% | 7.6% | 67 | 62 | 116.50 | +33.6% | 52 | 2.51 |
|
APOTEA
|
73.90 | 7.7B | 7.83 | 8.12 | 4.35 | 21.1% | 10.2% | 61 | 58 | 64.41 | -9.6% | 71 | 0.29 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.